Yet another therapy with FDA accelerated approval suffers a setback; Sage’s tough year continues; Sanofi drops $326 million ...

Here are five top Goldman Sachs dividend-paying stock picks that investors can buy now and hold for the next decade or longer ...

(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...

Its cheap valuation, strong growth prospects, and massive dividend make it ripe for outsize investment returns.

The approval for the vaccine, Abrysvo, in adults aged 18 to 59 was based on the results from a late stage trial in which two doses of the vaccine were teste ...

Discussing Pfizer's platform, the lawmakers write that it "creates the impression that any patient interested in a particular ...

Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...

AvenCell Therapeutics announced that it raised $115 million in a Series B round. The company is developing CAR-T therapies ...

Platelets are cells that help your blood clot, and it was so unusual to see blood clots combined with low platelet levels, ...

Zachary Levi, known for his role as the titular character in Shazam! Fury of the Gods, is facing financial difficulties after ...

Michela Tindera But despite losing Read and D’Amelio’s support, Starboard is still pushing ahead with its campaign. Yesterday, October 22nd, at an activist investor conference in New York, Starboard ...

Activist investors tend to rely on an element of surprise to catch their target company off guard: quietly building up a stake and swooping in with a slide deck full of strategic changes at just the ...